ALLERGAN PLC (NYSE:AGN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September25, 2017, Allergan plc (the “Company”) announced that Maria Teresa Hilado has decided to retire as Chief Financial Officer. Ms.Hilado informed the Company of her decision on September22, 2017. Ms.Hilado will continue in her current role until a successor is named. The Company has launched an executive search to fill the position.